| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |